Agios Pharma (AGIO), Celgene (CELG) Defer Rights Selection Process Under Collaboration, License Agreement
Tweet Send to a Friend
Agios Pharma (NASDAQ: AGIO) disclosed the following on Thursday.Item 8.01 Other Events.On April 13, 2016 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
